Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SciKon Innovation

2009 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$350K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a tissue engineering and biotechnology firm. The company utilizes human and animal primary cell cultures for predictive model biotools.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • P.O. Box 9100
  • Chapel Hill, NC 27515
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SciKon Innovation’s full profile, request a free trial.

SciKon Innovation Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 11-Sep-2015 $350K 00000 Completed Generating Revenue
3. Grant 15-Jun-2015 00000 000.00 Completed Generating Revenue
2. Debt - General 11-Feb-2014 $68.5K $68.5K Completed Startup
1. Grant 31-Jul-2012 $297K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

SciKon Innovation Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Science Foundation Government 000 0000 000000 0

SciKon Innovation Executive Team (3)

Name Title Board
Seat
Contact
Info
Randall McClelland Ph.D Founder, Chief Executive Officer, President & Board Member
Michael McCartney Chief Operating Officer & Board Member
Steve Paladino Board Member & Executive Officer

SciKon Innovation Board Members (4)

Name Representing Role Since Contact
Info
Jodi Kramer SciKon Innovation Board Member 000 0000
Michael McCartney SciKon Innovation Chief Operating Officer & Board Member 000 0000
Steve Paladino SciKon Innovation Board Member & Executive Officer 000 0000
Thomas Mercolino SciKon Innovation Board Member 000 0000